Rhinomed Ltd - ESG Rating & Company Profile powered by AI
The webpage displays a zero-cost Environmental, Social and Governance report covering Rhinomed Ltd. This assessment of Rhinomed Ltd is assembled by All Street Sevva using leading NLP. Complete Sustainability analysis of Rhinomed Ltd can be reached by logging in.
Rhinomed Ltd in the Pharmaceuticals industry gained a UN SDG ESG Transparency Score of 8.0; made up of an environmental score of 8.0, social score of 8.0 and governance score of 8.0.
8.0
High ImpactEnvironmental
Social
Governance

Peer Group Comparison
Rank | Company | SDG Transparency Score ⓘ | Performance |
---|---|---|---|
1 | Rhinomed Ltd | 8.0 | High |
1 | Caladrius Biosciences Inc | 8.0 | High |
1 | Can Fite Biopharma Ltd | 8.0 | High |
... | ... | ... | |
1970 | Zyden Gentec Ltd | 0.0 | Low |
1970 | iNtRON Biotechnology Inc | 0.0 | Low |
... | ... | ... |

Frequently Asked Questions
Does Rhinomed Ltd have an accelerator or VC vehicle to help deliver innovation?
Does Rhinomed Ltd disclose current and historical energy intensity?
Does Rhinomed Ltd report the average age of the workforce?
Does Rhinomed Ltd reference operational or capital allocation in relation to climate change?
Does Rhinomed Ltd disclose its ethnicity pay gap?
Does Rhinomed Ltd disclose cybersecurity risks?
Does Rhinomed Ltd offer flexible work?
Does Rhinomed Ltd have a long term incentive (LTI) executive compensation plan based on a measure of return on capital?
Does Rhinomed Ltd disclose the number of employees in R&D functions?
Does Rhinomed Ltd conduct supply chain audits?
Does Rhinomed Ltd disclose incidents of non-compliance in relation to the health and safety impacts of products and services?
Is there a statment that there is no plan to expand their cement production? (for example: 'We have no current plans to add additional cement making capacity')
Does Rhinomed Ltd conduct 360 degree staff reviews?
Does Rhinomed Ltd disclose the individual responsible for D&I?
Does Rhinomed Ltd disclose current and historical air emissions?
Is there a statment that there is no plan to expand their coal usage? (for example: 'We have no current plans to add additional coal powered electricity generation')
Is executive remuneration linked to climate performance?
Does the Board describe its role in the oversight of climate-related risks and opportunities?
Does Rhinomed Ltd disclose current and / or historical scope 2 emissions?
Does Rhinomed Ltd disclose water use targets?
Does Rhinomed Ltd have careers partnerships with academic institutions?
Did Rhinomed Ltd have a product recall in the last two years?
Does Rhinomed Ltd disclose incidents of discrimination?
Does Rhinomed Ltd allow for Work Councils/Collective Agreements to be formed?
Has Rhinomed Ltd issued a profit warning in the past 24 months?
Does Rhinomed Ltd disclose parental leave metrics?
Does Rhinomed Ltd disclose climate scenario or pathway analysis?
Does Rhinomed Ltd disclose current and / or historical scope 1 emissions?
Are Operating Expesnses linked to emissions reduction?
Does Rhinomed Ltd disclose the pay ratio of women to men?
Does Rhinomed Ltd support suppliers with sustainability related research and development?
Does Rhinomed Ltd disclose the number of operations that have been subject to human rights reviews or human rights impact assessments?
Does Rhinomed Ltd reflect climate-related risks in its financial statements?
Is there a statment that there is no plan to expand their carbon intensite energy assets? (for example: 'We have no current plans to carry out further drilling for oil,')
Is Rhinomed Ltd involved in embryonic stem cell research?
Does Rhinomed Ltd disclose GHG and Air Emissions intensity?
Does Rhinomed Ltd disclose its waste policy?
Does Rhinomed Ltd report according to TCFD requirements?
Does Rhinomed Ltd disclose its policies for bribery, corruption, whistle-blower, conflict of interest?
Does Rhinomed Ltd disclose energy use targets?
Does Rhinomed Ltd disclose its Renewable Energy targets?

Are emissions metrics verified by STBi?

Does Rhinomed Ltd have a policy relating to cyber security?
Have a different question?
Potential Risks for Rhinomed Ltd
These potential risks are based on the size, segment and geographies of the company.
Rhinomed Limited engages in the research, development, and commercialization of consumer and medical devices worldwide. It offers wearable nasal technology that improve breathing, sleeping, and maintaining health and diagnose disease. The company's products include Turbine for enhanced breathing in sports; Mute, which helps to breath more and snore less; Pronto, a vapor inhaler to improve airflow and better sleep; and Rhinoswab that is used to collect a nasal swab. It also engages in developing programs in various markets, including sleep and sleep architecture, the impact of sleep and respiratory, function on cognitive issues, obstructive sleep apnea, pain, nausea, respiratory disease, and diagnostics and sensors; and offers a drug delivery platform for the delivery of cannabinoid formulations. The company was formerly known as Consegna Group Limited and changed its name to Rhinomed Limited in November 2013. Rhinomed Limited was incorporated in 2004 and is headquartered in Cremorne, Australia.